The Critical Pulmonary Embolism Patient
November 6, 2017
Background: Previously, I had given a talk on the use of thrombolytics in submassive PE in 2016. This year, I had the privilege of speaking...
Marco Torres
The Death of MONA in ACS: Part IV – Aspirin
November 5, 2017
Background: Aspirin is the most widely used antiplatelet agent in acute coronary syndromes. The bulk of the evidence for this came from the second international study...
The Death of MONA in ACS: Part III – Nitroglycerin
Background: Nitroglycerin is a first line agent in the treatment of ACS. The physiologic basis for it’s use rests on it’s ability to promote coronary...
The Death of MONA in ACS: Part II – Oxygen
Background: The first report for supplemental oxygen for angina was in 1900, and since then oxygen therapy has been a commonly used treatment of patients...
The Death of MONA in ACS: Part I – Morphine
Background: Morphine is a commonly used medication in acute coronary syndromes (ACS) to help relieve pain which in turn can help reduce sympathetic tone. Over...